New Study Explores Treatment Options for Symptomatic Brain Cavernoma
This study looked at how to best treat brain cavernomas, which are abnormal blood vessel clusters in the brain that can cause symptoms like seizures or bleeding.
-
-
GLP-1 Receptor Agonists Offer Benefits for Type 2 Diabetes Care
Researchers studied the effects of a type of diabetes medication called glucagon-like peptide-1 receptor agonists (GLP-1RAs) in adults with type 2 diabetes (T2D).
-
Improving Access to Genetic Testing for Neurodevelopmental Disorders
This study looked at how genetic testing is used to diagnose neurodevelopmental disorders (NDDs) in Israel, focusing on children born between 2000 and 2020.
-
Understanding MRI-Negative Epilepsy and Its Challenges
This study looked at people with drug-resistant focal epilepsy who had negative MRI results, meaning no visible lesions were found on their scans.
-
Safe and Efficient Use of Antiseizure Medications
Researchers studied the safety and effectiveness of quickly giving antiseizure medications (ASMs) to patients, focusing on three specific drugs: lacosamide, levetiracetam, and valproate.
-
Understanding Medical Cannabis Regulations in the US, EU, and UK
This study looked at how medical cannabis is regulated in the United States, the European Union, and the United Kingdom.
-
Personalized Seizure Risk Predictions for Better Epilepsy Care
Researchers studied how to better predict the risk of seizures in people with epilepsy, focusing on those who have had a single seizure or are at risk due to conditions like stroke or brain injury.
-
Cognitive Assessments for Children with Cerebral Palsy Explained
This study looked at how cognitive abilities are assessed in children with cerebral palsy (CP).
-
Drug-Resistant Epilepsy | Epilepsy Research Summaries | Imaging & EEG | Pediatrics | Recent Research
Automated Algorithms Improve Detection of Epilepsy in Children
This study focused on finding better ways to detect focal cortical dysplasia type II (FCD type II) in children, a condition that can cause severe epilepsy that doesn’t respond to medication.
